These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18280)
1. A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody. Okabayashi T; Mihara S; Repke DB; Moffatt JG Cancer Res; 1977 Sep; 37(9):3132-5. PubMed ID: 18280 [TBL] [Abstract][Full Text] [Related]
2. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine. Okabayashi T; Mihara S; Moffatt JG Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864 [TBL] [Abstract][Full Text] [Related]
3. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine. Okabayashi T; Mihara S; Repke DB; Moffatt JG Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282 [TBL] [Abstract][Full Text] [Related]
4. Sensitive radioimmunoassay for cytarabine and uracil arabinoside in plasma. Sato T; Morozumi M; Kodama K; Kuninaka A; Yoshino H Cancer Treat Rep; 1984 Nov; 68(11):1357-66. PubMed ID: 6498853 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells. Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754 [TBL] [Abstract][Full Text] [Related]
6. Extraction and analytic procedures for cytosine arabinoside and 1-beta-D-arabinofuranosyluracil and their 5'-mono-, di-, and tri-phosphates. Kreis W; Gordon C; Gizoni C; Woodcock T Cancer Treat Rep; 1977 Jul; 61(4):643-6. PubMed ID: 195728 [TBL] [Abstract][Full Text] [Related]
7. Separation of 5'-mono-, di- and triphosphates of 1-beta-D-arabinofuranosylcytosine and of 1-beta-D-arabinofuranosyluracil by thin-layer and high pressure liquid chromatography. Kreis W; Greenspan A; Woodcock T; Gordon C J Chromatogr Sci; 1976 Jul; 14(7):331-3. PubMed ID: 956325 [TBL] [Abstract][Full Text] [Related]
8. A radioimmunoassay for cytosine arabinoside. Piall EM; Aherne GW; Marks VM Br J Cancer; 1979 Oct; 40(4):548-56. PubMed ID: 574019 [TBL] [Abstract][Full Text] [Related]
9. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance. Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444 [TBL] [Abstract][Full Text] [Related]
10. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells. Tsuruo T; Iida H; Hori K; Tsukagoshi S; Sakurai Y Cancer Res; 1981 Nov; 41(11 Pt 1):4484-8. PubMed ID: 7306971 [TBL] [Abstract][Full Text] [Related]
11. Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Damon LE; Plunkett W; Linker CA Cancer Res; 1991 Aug; 51(16):4141-5. PubMed ID: 1868435 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia. Ueda T; Nakamura T; Ando S; Kagawa D; Sasada M; Uchino H; Johno I; Akiyama Y Cancer Res; 1983 Jul; 43(7):3412-6. PubMed ID: 6850647 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice. Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 2'-fluoro-arabinosyl pyrimidine nucleosides and 1-beta-D-arabinofuranosylcytosine on immunological parameters in vitro. Merluzzi VJ; Last-Barney K; Fox JJ Int J Immunopharmacol; 1983; 5(5):421-5. PubMed ID: 6686216 [TBL] [Abstract][Full Text] [Related]
16. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Kees UR; Ford J; Dawson VM; Piall E; Aherne GW Cancer Res; 1989 Jun; 49(11):3015-9. PubMed ID: 2720661 [TBL] [Abstract][Full Text] [Related]
17. Preparation and properties of O'-methyl and O'-ethyl derivatives of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil. Darzynkiewicz E; Shugar D Acta Biochim Pol; 1974; 21(3):305-22. PubMed ID: 4440349 [No Abstract] [Full Text] [Related]
18. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid. Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of 1-β-d-Arabinofuranosylcytosine and two metabolites, 1-β-d-Arabinofuranosyluracil and 1-β-d-Arabinofuranosylcytosine triphosphate in leukemic cell by HPLC-MS/MS and the application to cell pharmacokinetics. Liang D; Wang W; Jiang X; Yin S J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():14-19. PubMed ID: 24880220 [TBL] [Abstract][Full Text] [Related]
20. [The simultaneous determination of Ara-U and Ara-C, urinary metabolites of N4-behenoyl-1-beta-D-arabinofuranosylcytosine by mass fragmentography (author's transl)]. Makino Y; Matsubara Y; Watanabe K; Hirobe M Yakugaku Zasshi; 1982 Jan; 102(1):49-55. PubMed ID: 7086638 [No Abstract] [Full Text] [Related] [Next] [New Search]